Mohammed Solomon Ahmed, Workneh Birhanu Demeke
Department of Pharmacy, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.
Integr Pharm Res Pract. 2020 Sep 9;9:113-125. doi: 10.2147/IPRP.S265438. eCollection 2020.
Inventory management is a complex process that accelerates the probability of stock-out and overstocking if not tracked properly. Classification of drugs based on their criticality, cost burden, and in combination is important to make inventory decisions and optimize the quality use of scarce resources. This study analyzed the pharmaceutical inventory management systems of Dessie Referral Hospital using the ABC-VEN matrix for the years 2013 to 2017.
Cross-sectional study design was used to review logistic data retrospectively from health commodity management information system and manual records. Data were collected from January 1-20, 2018 in Dessie Referral Hospital.
In the five-year ABC-VEN analysis, 310 (17%), 368 (20.18%), and 1146 (62.83%) items were class A, B, and C, while 610 (34.56%), 1125 (63.74%), and 30 (1.7%) of pharmaceuticals were V, E, and N, respectively. Among these, 139 (7.88%) and 339 (19.21%) of AV and CV pharmaceuticals utilized 43.52% and 2.89% of annual drug expenditures, respectively. Category I, II, and III pharmaceuticals also accounted for 43.68%, 54.79%, and 1.53% of items with their respective USD drug expenditure of 2,268,405.64 (84.49%), 411,961.18 (15.34%), and 4483.97 (0.17%). The pharmaceutical inventory cost projected to be 1,619,351.79 USD in 2025 and total cost (β= 10.68, p = 0.001), class A (β= 8.68, p = 0.001), class B (β= 1.27, p = 0.007), class C (β= 0.72, p = 0.03), and E items (β= 6.08, p = 0.01) were statistically significant with inventory cost.
A huge amount of budget is invested in class A and category I, which pinpoints the need for strict inventory control to prevent wastage and accumulation of capital in buffer stocks. ABC-VEN analysis should be routinely performed before initiation of any new procurement for efficient use of scarce resources.
库存管理是一个复杂的过程,如果跟踪不当,会增加缺货和库存积压的可能性。根据药品的关键性、成本负担以及两者结合进行分类,对于做出库存决策和优化稀缺资源的合理利用非常重要。本研究使用ABC-VEN矩阵分析了2013年至2017年德西转诊医院的药品库存管理系统。
采用横断面研究设计,回顾性审查卫生商品管理信息系统和手工记录中的物流数据。数据于2018年1月1日至20日在德西转诊医院收集。
在为期五年的ABC-VEN分析中,310项(17%)、368项(20.18%)和1146项(62.83%)分别为A类、B类和C类,而药品中610项(34.56%)、1125项(63.74%)和30项(1.7%)分别为V类、E类和N类。其中,139项(7.88%)的AV类药品和339项(19.21%)的CV类药品分别占年度药品支出的43.52%和2.89%。I类、II类和III类药品也分别占药品项目的43.68%、54.79%和1.53%,其各自的药品支出为2,268,405.64美元(84.49%)、411,961.18美元(15.34%)和4483.97美元(0.17%)。预计2025年药品库存成本为1,619,351.79美元,总成本(β= 10.68,p = 0.001)、A类(β= 8.68,p = 0.001)、B类(β= 1.27,p = 0.007)、C类(β= 0.72,p = 0.03)和E类项目(β= 6.08,p = 0.01)与库存成本具有统计学意义。
A类和I类药品投入了大量预算,这表明需要严格的库存控制,以防止缓冲库存中的浪费和资金积累。在开始任何新的采购之前,应定期进行ABC-VEN分析,以有效利用稀缺资源。